These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 31150696)

  • 1. Single-cell analysis of cytoskeleton dynamics: From isoelectric focusing to live cell imaging and RNA-seq.
    Gozes I; Ivashko-Pachima Y; Kapitansky O; Sayas CL; Iram T
    J Neurosci Methods; 2019 Jul; 323():119-124. PubMed ID: 31150696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADNP/NAP dramatically increase microtubule end-binding protein-Tau interaction: a novel avenue for protection against tauopathy.
    Ivashko-Pachima Y; Sayas CL; Malishkevich A; Gozes I
    Mol Psychiatry; 2017 Sep; 22(9):1335-1344. PubMed ID: 28115743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The NAP motif of activity-dependent neuroprotective protein (ADNP) regulates dendritic spines through microtubule end binding proteins.
    Oz S; Kapitansky O; Ivashco-Pachima Y; Malishkevich A; Giladi E; Skalka N; Rosin-Arbesfeld R; Mittelman L; Segev O; Hirsch JA; Gozes I
    Mol Psychiatry; 2014 Oct; 19(10):1115-24. PubMed ID: 25178163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity-dependent neuroprotective protein (ADNP)-end-binding protein (EB) interactions regulate microtubule dynamics toward protection against tauopathy.
    Ivashko-Pachima Y; Gozes I
    Prog Mol Biol Transl Sci; 2021; 177():65-90. PubMed ID: 33453943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sexual divergence in microtubule function: the novel intranasal microtubule targeting SKIP normalizes axonal transport and enhances memory.
    Amram N; Hacohen-Kleiman G; Sragovich S; Malishkevich A; Katz J; Touloumi O; Lagoudaki R; Grigoriadis NC; Giladi E; Yeheskel A; Pasmanik-Chor M; Jouroukhin Y; Gozes I
    Mol Psychiatry; 2016 Oct; 21(10):1467-76. PubMed ID: 26782054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel davunetide (NAPVSIPQQ to NAPVSIPQE) point mutation in activity-dependent neuroprotective protein (ADNP) causes a mild developmental syndrome.
    Gozes I; Shazman S
    Eur J Neurosci; 2023 Jul; 58(2):2641-2652. PubMed ID: 36669790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microtubules (tau) as an emerging therapeutic target: NAP (davunetide).
    Gozes I
    Curr Pharm Des; 2011; 17(31):3413-7. PubMed ID: 21902667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Introducing ADNP and SIRT1 as new partners regulating microtubules and histone methylation.
    Hadar A; Kapitansky O; Ganaiem M; Sragovich S; Lobyntseva A; Giladi E; Yeheskel A; Avitan A; Vatine GD; Gurwitz D; Ivashko-Pachima Y; Gozes I
    Mol Psychiatry; 2021 Nov; 26(11):6550-6561. PubMed ID: 33967268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ADNP/ADNP2 expression in oligodendrocytes: implication for myelin-related neurodevelopment.
    Malishkevich A; Leyk J; Goldbaum O; Richter-Landsberg C; Gozes I
    J Mol Neurosci; 2015 Oct; 57(2):304-13. PubMed ID: 26315608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cytoskeleton as a drug target for neuroprotection: the case of the autism- mutated ADNP.
    Gozes I
    Biol Chem; 2016 Mar; 397(3):177-84. PubMed ID: 25955282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SH3- and actin-binding domains connect ADNP and SHANK3, revealing a fundamental shared mechanism underlying autism.
    Ivashko-Pachima Y; Ganaiem M; Ben-Horin-Hazak I; Lobyntseva A; Bellaiche N; Fischer I; Levy G; Sragovich S; Karmon G; Giladi E; Shazman S; Barak B; Gozes I
    Mol Psychiatry; 2022 Aug; 27(8):3316-3327. PubMed ID: 35538192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity-dependent neuroprotective protein deficiency models synaptic and developmental phenotypes of autism-like syndrome.
    Hacohen-Kleiman G; Sragovich S; Karmon G; Gao AYL; Grigg I; Pasmanik-Chor M; Le A; Korenková V; McKinney RA; Gozes I
    J Clin Invest; 2018 Nov; 128(11):4956-4969. PubMed ID: 30106381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single Cell ADNP Predictive of Human Muscle Disorders: Mouse Knockdown Results in Muscle Wasting.
    Kapitansky O; Karmon G; Sragovich S; Hadar A; Shahoha M; Jaljuli I; Bikovski L; Giladi E; Palovics R; Iram T; Gozes I
    Cells; 2020 Oct; 9(10):. PubMed ID: 33086621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection against tauopathy by the drug candidates NAP (davunetide) and D-SAL: biochemical, cellular and behavioral aspects.
    Shiryaev N; Pikman R; Giladi E; Gozes I
    Curr Pharm Des; 2011; 17(25):2603-12. PubMed ID: 21728979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The femtomolar-acting NAP interacts with microtubules: Novel aspects of astrocyte protection.
    Gozes I; Divinski I
    J Alzheimers Dis; 2004 Dec; 6(6 Suppl):S37-41. PubMed ID: 15665412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microtubule-stabilizing peptides and small molecules protecting axonal transport and brain function: focus on davunetide (NAP).
    Magen I; Gozes I
    Neuropeptides; 2013 Dec; 47(6):489-95. PubMed ID: 24210139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tauopathy in the young autistic brain: novel biomarker and therapeutic target.
    Grigg I; Ivashko-Pachima Y; Hait TA; Korenková V; Touloumi O; Lagoudaki R; Van Dijck A; Marusic Z; Anicic M; Vukovic J; Kooy RF; Grigoriadis N; Gozes I
    Transl Psychiatry; 2020 Jul; 10(1):228. PubMed ID: 32661233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NAP (davunetide) preferential interaction with dynamic 3-repeat Tau explains differential protection in selected tauopathies.
    Ivashko-Pachima Y; Maor-Nof M; Gozes I
    PLoS One; 2019; 14(3):e0213666. PubMed ID: 30865715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New horizons in schizophrenia treatment: autophagy protection is coupled with behavioral improvements in a mouse model of schizophrenia.
    Merenlender-Wagner A; Shemer Z; Touloumi O; Lagoudaki R; Giladi E; Andrieux A; Grigoriadis NC; Gozes I
    Autophagy; 2014; 10(12):2324-32. PubMed ID: 25484074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ADNP derived peptide, NAP modulates the tubulin pool: implication for neurotrophic and neuroprotective activities.
    Oz S; Ivashko-Pachima Y; Gozes I
    PLoS One; 2012; 7(12):e51458. PubMed ID: 23272107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.